In this episode, I sat down with Emma Silverman, Partner at TMV, to explore her path into venture and TMV’s purpose-driven origin story. We discuss TMV’s health & bio thesis, notable investments such as Slingshot AI and Elion, and Emma’s recent research on the promise and tension of clinical AI adoption across health systems and payers. She also shares practical advice for early-stage founders navigating uncertainty and offers candid guidance for aspiring investors on finding their own style in venture.